Compliance Question of the Week – Laboratory

In a case where multiple specimens are processed on the same date of service, how should 88362 and 88380 be reported, and what documentation requirements must be met to ensure correct billing? Additionally, under what circumstances can a modifier be appended to 88380?

What is the reporting rule for colony count restrictions and unique isolates when it comes to reporting 87088?

Do we report 86003 only once for allergy testing services as a comprehensive code?

Can we report 88388 for the capture of interdepartmental examination of tissue specimens when it is submitted for further study i.e. genetic analysis?

What codes do we report for in situ Hybridization when it comes to multiplex staining procedures?

What codes are used to bill for situ hybridization?

What codes are used to report cytopathology procedures and smears, and which codes are used for histology procedures and stains?

What codes would we report for HIV-preventing screening?

Can we report 36415 for finger sticks or draw lines? What are the status indicators for this code in 2024?

Are there still coding and compliance risks posed by COVID-19 testing and protocol? Is there a potential for audits in the future?

Why should codes 88362 and 88380-88381 not be billed together on the same date of service?

Can you clarify the coding relationship for flow cytometry codes between physician interpretation and markers analyzed?